HBK Sorce Advisory »

Lexicon Pharmaceuticals shares owned by HBK Sorce Advisory

Quarter-by-quarter ownership of Lexicon Pharmaceuticals (LXRX) shares owned by HBK Sorce Advisory from 13F filings

Historical chart of HBK Sorce Advisory investment in Lexicon Pharmaceuticals

Tip: Access up to 7 years of quarterly data

All positions including Lexicon Pharmaceuticals held by HBK Sorce Advisory consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Lexicon Pharmaceuticals by HBK Sorce Advisory

Quarter filed Position value Share count Share price at filing
2025-09-30 $18k 12k 1.53
2025-06-30 $11k 12k 0.95

More positions owned by HBK Sorce Advisory

Schwab Strategic Tr Us Lrg Cap Etf (SCHX)
Vanguard Malvern Fds Core Bd Etf (VCRB)
Vanguard Tax-managed Fds Van Ftse Dev Mkt (VEA)
Dimensional Etf Trust Us Large Cap Vec (DFVX)
Apple (AAPL)
Schwab Strategic Tr Us Brd Mkt Etf (SCHB)
Vanguard Index Fds S&p 500 Etf Shs (VOO)
Schwab Strategic Tr Emrg Mkteq Etf (SCHE)
Invesco Exch Trd Slf Idx Rusl 1000 Dynm (OMFL)
Microsoft Corporation (MSFT)
Dimensional Etf Trust Core Fixed Incom (DFCF)
NVIDIA Corporation (NVDA)
Vanguard Mun Bd Fds Tax Exempt Bd (VTEB)
JPMorgan Chase & Co. (JPM)
Vanguard Index Fds Total Stk Mkt (VTI)

View all positions for HBK Sorce Advisory

Top funds holding Lexicon Pharmaceuticals

Artal Group
Siren
FMR
Vanguard Group
Millennium Management
BlackRock
Citadel Advisors
Sessa Capital IM
Atlantic Trust
Geode Capital Management
Caption Management
Susquehanna International
GSA Capital Partners
Charles Schwab Investment Management
State Street Corporation

View all funds holding Lexicon Pharmaceuticals